ER+ BC is relatively genomically stable with a primary dependency on estrogen signaling, and it typically has normal function of RB and p53 tumor suppressor pathways compared to other BC subtypes, such as HER2+ and TNBC. The gene discussed is ESR1; the disease is breast cancer.